Skip to main content
. Author manuscript; available in PMC: 2015 Nov 20.
Published in final edited form as: Vaccine. 2013 Jul 2;31(0 3):C88–C93. doi: 10.1016/j.vaccine.2013.05.036

Table 1.

Syndromes and age groups targeted for surveillance, samples collected for each syndrome, and processing of specimens: integrated vaccine-preventable disease surveillance system, Costa Rica, September 2009–August 2010.

Syndrome Age group targeted for
surveillance
Specimen type(s) Laboratory
diagnostic
procedures
Etiologic agents
evaluated
Processing lab location
Meningitis <5 years Cerebrospinal fluid, blood Gram stain, latex
agglutination test,
culture, typing,
antimicrobial
susceptibility
testing
S. pneumoniae, N.
meningitidis, H.
influenzae, other
Streptococcus
Sentinel hospital
laboratory, INCIENSA
Acute flaccid paralysis <15 years Stool PCR
Viral isolation
Poliovirus
Poliovirus
INCIENSA
INCIENSA,
international/regional
reference laboratory
Severe acute diarrhea <5 years Stool Latex agglutination
test
ELISA
Rotavirus

Rotavirus
Sentinel hospital

INCIENSA
Rash and fever illness All ages Blood ELISA
Genotyping
Measles/rubella/dengue
Measles/rubella
INCIENSA
INCIENSA
Severe acute
respiratory illness
≥5 years Nasopharingeal/oropharingeal
aspirate
Chest radiograph,
blood culture
S. pneumoniae, H.
influenzae
B. pertussis,
influenza virus,
respiratory
syncitial virus,
adenovirus,
parainfluenza virus
types 1–3
Sentinel hospital
laboratory
INCIENSA
<5 years Nasopharingeal/oropharingeal
aspirate, blood, chest X-ray
Immunofluorescence,
PCR, viral isolation

Note. PCR: polymerase chain reaction; ELISA: enzyme-linked immunosorbent assay.